CRP Regimen in Treating Elderly Patients With Previously Untreated Double-Positive DLBCL

Abroad (travel likely)RecruitingPHASE2

Conditions

Diffuse Large B-Cell Lymphoma (DLBCL)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Tianjin Medical University Cancer Insititute & Hospital, Tianjin, Tianjin Municipality, China

Study leads

Huilai Zhang
Study Director
Tianjin Medical University Cancer Insititute & Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Efficacy and Safety of Pola-RCHP-X vs Pola-RCHP in Untreated DLBCL

Diffuse Large B-Cell Lymphoma

Abroad (travel likely)RecruitingPHASE2

Shanghai, China

Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma

Non-Hodgkin's Lymphoma · Diffuse Large B-Cell Lymphoma · DLBCL

Abroad (travel likely)RecruitingPHASE2

Bethesda, United States

Chidamide for Maintenance Treatment of HBV-infected Diffuse DLBCL in Patients Initially Treated With R-CHOP

Diffuse Large B-Cell Lymphoma (DLBCL)

Abroad (travel likely)RecruitingPHASE3

Changchun, China

Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia Patients

Relapsed Large B-cell Lymphoma · Refractory Large B-cell Lymphoma · Diffuse Large B-cell Lymphoma (DLBCL)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Seoul, South Korea · Seoul, South Korea